These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25350366)

  • 61. An exploration of the effect of modafinil on olanzapine associated weight gain in normal human subjects.
    Roerig JL; Steffen KJ; Mitchell JE; Crosby RD; Gosnell BA
    Biol Psychiatry; 2009 Apr; 65(7):607-13. PubMed ID: 19103435
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Course of weight gain and metabolic abnormalities in first treated episode of psychosis: the first year is a critical period for development of cardiovascular risk factors.
    Pérez-Iglesias R; Martínez-García O; Pardo-Garcia G; Amado JA; Garcia-Unzueta MT; Tabares-Seisdedos R; Crespo-Facorro B
    Int J Neuropsychopharmacol; 2014 Jan; 17(1):41-51. PubMed ID: 24103107
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: implications for animal models of antipsychotic-induced weight gain.
    Cooper GD; Harrold JA; Halford JC; Goudie AJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):428-36. PubMed ID: 17933447
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Modelling olanzapine-induced weight gain in rats.
    van der Zwaal EM; Janhunen SK; la Fleur SE; Adan RA
    Int J Neuropsychopharmacol; 2014 Jan; 17(1):169-86. PubMed ID: 24103788
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Weight gain, obesity, and metabolic indices following a first manic episode: prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM).
    Bond DJ; Kauer-Sant'Anna M; Lam RW; Yatham LN
    J Affect Disord; 2010 Jul; 124(1-2):108-17. PubMed ID: 19914720
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A low TSH profile predicts olanzapine-induced weight gain and relief by adjunctive topiramate in healthy male volunteers.
    Evers SS; van Vliet A; van Vugt B; Scheurink AJ; van Dijk G
    Psychoneuroendocrinology; 2016 Apr; 66():101-10. PubMed ID: 26802597
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Efficacy of ranitidine in olanzapine-induced weight gain: a dose-response study.
    Mehta VS; Ram D
    Early Interv Psychiatry; 2016 Dec; 10(6):522-527. PubMed ID: 25529756
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Weight gain and ghrelin level after olanzapine monotherapy.
    Chen VC; Wang TN; Lu ML; Chou JY; Ju PC; Wu JY; Lin ZR; Ji TT; Chou CE; Lee CT; Lai TJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):632-5. PubMed ID: 21256176
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of peanut oil load on energy expenditure, body composition, lipid profile, and appetite in lean and overweight adults.
    Coelho SB; de Sales RL; Iyer SS; Bressan J; Costa NM; Lokko P; Mattes R
    Nutrition; 2006 Jun; 22(6):585-92. PubMed ID: 16704951
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The atypical antipsychotic olanzapine causes weight gain by targeting serotonin receptor 2C.
    Lord CC; Wyler SC; Wan R; Castorena CM; Ahmed N; Mathew D; Lee S; Liu C; Elmquist JK
    J Clin Invest; 2017 Sep; 127(9):3402-3406. PubMed ID: 28805659
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy.
    Demark-Wahnefried W; Peterson BL; Winer EP; Marks L; Aziz N; Marcom PK; Blackwell K; Rimer BK
    J Clin Oncol; 2001 May; 19(9):2381-9. PubMed ID: 11331316
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Olanzapine-induced weight gain and increased visceral adiposity is blocked by melatonin replacement therapy in rats.
    Raskind MA; Burke BL; Crites NJ; Tapp AM; Rasmussen DD
    Neuropsychopharmacology; 2007 Feb; 32(2):284-8. PubMed ID: 16710316
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Selective glucocorticoid receptor (type II) antagonists prevent weight gain caused by olanzapine in rats.
    Belanoff JK; Blasey CM; Clark RD; Roe RL
    Eur J Pharmacol; 2011 Mar; 655(1-3):117-20. PubMed ID: 21269600
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Betahistine decreases olanzapine-induced weight gain and somnolence in humans.
    Barak N; Beck Y; Albeck JH
    J Psychopharmacol; 2016 Mar; 30(3):237-41. PubMed ID: 26839321
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Chronic olanzapine administration in rats: effect of route of administration on weight, food intake and body composition.
    Mann S; Chintoh A; Giacca A; Fletcher P; Nobrega J; Hahn M; Remington G
    Pharmacol Biochem Behav; 2013 Feb; 103(4):717-22. PubMed ID: 23234835
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Samidorphan mitigates olanzapine-induced weight gain and metabolic dysfunction in rats and non-human primates.
    Cunningham JI; Eyerman DJ; Todtenkopf MS; Dean RL; Deaver DR; Sanchez C; Namchuk M
    J Psychopharmacol; 2019 Oct; 33(10):1303-1316. PubMed ID: 31294646
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Contribution of parasympathetic muscarinic augmentation of insulin secretion to olanzapine-induced hyperinsulinemia.
    Rickels MR; Perez EM; Peleckis AJ; Alshehabi E; Nguyen HL; Stefanovski D; Rickels K; Teff KL
    Am J Physiol Endocrinol Metab; 2018 Aug; 315(2):E250-E257. PubMed ID: 29351487
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Weight changes over time in adults treated with the oral or depot formulations of olanzapine: a pooled analysis of 86 clinical trials.
    Millen BA; Campbell GM; Beasley CM
    J Psychopharmacol; 2011 May; 25(5):639-45. PubMed ID: 20558497
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Olanzapine-depot administration induces time-dependent changes in adipose tissue endocrine function in rats.
    Horska K; Ruda-Kucerova J; Babinska Z; Karpisek M; Demlova R; Opatrilova R; Suchy P; Kotolova H
    Psychoneuroendocrinology; 2016 Nov; 73():177-185. PubMed ID: 27504985
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Olanzapine and food craving: a case control study.
    Abbas MJ; Liddle PF
    Hum Psychopharmacol; 2013 Jan; 28(1):97-101. PubMed ID: 23169487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.